Trial Profile
A phase III study of ramoplanin in patients with bloodstream infections caused by vancomycin-resistant enterococci (VRE)
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 19 Oct 2015
Price :
$35
*
At a glance
- Drugs Ramoplanin (Primary)
- Indications Vancomycin-resistant enterococcal infections
- Focus Therapeutic Use
- 19 Oct 2015 New trial record